Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ANI PHARMACEUTICALS INCANIP · Entity 4638 | SR. VP, GENERAL COUNSEL & SEC. | October 13, 2026 | October 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ANI PHARMACEUTICALS INC
Report date October 13, 2026 · Filed October 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 73,424 |
Reported balance
After 2026-10-13 transaction · row 1
1 source rowRow 1 · 2026-10-13 · Sale · Disposed 500 · Balance 73,424 F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 13, 2026 Filed Oct 14, 2026 00:47 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 500 | $73.59 | $36,795.00 |
DisclosureSEC source: 0001938861-26-000028 · wk-form4_1791938859.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,424 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 00:56 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 500 | $70.79 | $35,395.00 |
DisclosureSEC source: 0001938861-26-000026 · wk-form4_1789433811.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,924 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. Read SEC document |
| August 13, 2026 Filed Aug 13, 2026 20:32 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 500 | $75.48 | $37,740.00 |
DisclosureSEC source: 0001938861-26-000023 · wk-form4_1786653146.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,424 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. Read SEC document |
| July 18, 2026 Filed Jul 21, 2026 20:32 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 2,466 | $79.20 | $195,307.20 |
DisclosureSEC source: 0001938861-26-000021 · wk-form4_1784665922.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,924 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,820 shares of restricted stock, the grant of which was previously reported on July 20, 2022. Read SEC document |
| July 13, 2026 Filed Jul 14, 2026 20:02 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 500 | $81.84 | $40,920.00 |
DisclosureSEC source: 0001938861-26-000019 · wk-form4_1784059323.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 77,390 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. Read SEC document |
| June 12, 2026 Filed Jun 15, 2026 22:44 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 500 | $82.03 | $41,015.00 |
DisclosureSEC source: 0001938861-26-000017 · wk-form4_1781563468.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 77,890 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. Read SEC document |
| May 13, 2026 Filed May 13, 2026 20:15 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 500 | $78.16 | $39,080.00 |
DisclosureSEC source: 0001938861-26-000015 · wk-form4_1778703326.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,390 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. Read SEC document |
| April 13, 2026 Filed Apr 13, 2026 20:40 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 500 | $77.95 | $38,975.00 |
DisclosureSEC source: 0001938861-26-000013 · wk-form4_1776112832.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,890 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. Read SEC document |
| March 13, 2026 Filed Mar 13, 2026 21:28 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 500 | $72.62 | $36,310.00 |
DisclosureSEC source: 0001938861-26-000010 · wk-form4_1773437283.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,390 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. Read SEC document |
| February 28, 2026 Filed Mar 2, 2026 22:57 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,555 | $73.90 | $114,914.50 |
DisclosureSEC source: 0001938861-26-000008 · wk-form4_1772492262.xml · nonDerivative · entry 2 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,890 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,040 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:57 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 13,895 | $77.15 | $1,071,999.25 |
DisclosureSEC source: 0001938861-26-000008 · wk-form4_1772492262.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,445 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026. Read SEC document |
| February 14, 2026 Filed Feb 17, 2026 21:04 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,779 | $77.36 | $137,623.44 |
DisclosureSEC source: 0001938861-26-000006 · wk-form4_1771362255.xml · nonDerivative · entry 3 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,550 F3 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,691 shares of restricted stock, the grant of which was previously reported on February 16, 2024. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:04 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 500 | $76.80 | $38,400.00 |
DisclosureSEC source: 0001938861-26-000006 · wk-form4_1771362255.xml · nonDerivative · entry 2 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,329 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:04 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,534 | $76.70 | $117,657.80 |
DisclosureSEC source: 0001938861-26-000006 · wk-form4_1771362255.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,829 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,243 shares of restricted stock, the grant of which was previously reported on February 18, 2025. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:13 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 3,011 | $76.25 | $229,588.75 |
DisclosureSEC source: 0001938861-26-000004 · wk-form4_1771017195.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,363 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 8,104 performance stock units, the grant of which was previously reported on April 6, 2023. Read SEC document |
| January 13, 2026 Filed Jan 14, 2026 23:14 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 500 | $84.33 | $42,165.00 |
DisclosureSEC source: 0001938861-26-000002 · wk-form4_1768432456.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,374 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2025. Read SEC document |
| December 12, 2025 Filed Dec 12, 2025 21:26 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 400 | $82.32 | $32,928.00 |
DisclosureSEC source: 0001938861-25-000030 · wk-form4_1765574758.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,874 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024. Read SEC document |
| November 13, 2025 Filed Nov 14, 2025 21:26 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 400 | $87.27 | $34,908.00 |
DisclosureSEC source: 0001938861-25-000028 · wk-form4_1763155617.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,274 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024. Read SEC document |
| October 13, 2025 Filed Oct 14, 2025 23:49 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 400 | $90.09 | $36,036.00 |
DisclosureSEC source: 0001938861-25-000026 · wk-form4_1760485793.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,674 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024. Read SEC document |
| September 12, 2025 Filed Sep 15, 2025 23:16 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 400 | $98.42 | $39,368.00 |
DisclosureSEC source: 0001938861-25-000024 · wk-form4_1757978190.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,074 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024. Read SEC document |
| August 13, 2025 Filed Aug 14, 2025 21:43 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 400 | $88.87 | $35,548.00 |
DisclosureSEC source: 0001938861-25-000020 · wk-form4_1755207827.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,474 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024. Read SEC document |
| July 18, 2025 Filed Jul 21, 2025 20:12 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 2,071 | $66.30 | $137,307.30 |
DisclosureSEC source: 0001938861-25-000018 · wk-form4_1753128770.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,874 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,820 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| July 14, 2025 Filed Jul 14, 2025 20:11 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 400 | $64.88 | $25,952.00 |
DisclosureSEC source: 0001938861-25-000016 · wk-form4_1752523859.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,945 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 21:24 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 400 | $61.37 | $24,548.00 |
DisclosureSEC source: 0001938861-25-000014 · wk-form4_1750109077.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,345 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024. Read SEC document |
| May 13, 2025 Filed May 13, 2025 20:29 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 400 | $62.20 | $24,880.00 |
DisclosureSEC source: 0001938861-25-000012 · wk-form4_1747168179.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,745 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024. Read SEC document |
| April 14, 2025 Filed Apr 14, 2025 20:17 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 400 | $68.96 | $27,584.00 |
DisclosureSEC source: 0001938861-25-000010 · wk-form4_1744661821.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,145 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024. Read SEC document |
| March 13, 2025 Filed Mar 14, 2025 21:28 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 400 | $63.33 | $25,332.00 |
DisclosureSEC source: 0001938861-25-000008 · wk-form4_1741987671.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,545 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 22:04 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,099 | $61.89 | $68,017.11 |
DisclosureSEC source: 0001938861-25-000006 · wk-form4_1741125873.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,945 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,039 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 01:12 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,434 | $58.92 | $84,491.28 |
DisclosureSEC source: 0001938861-25-000004 · wk-form4_1739927525.xml · nonDerivative · entry 4 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,044 F4 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,690 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 13, 2025 Filed Feb 19, 2025 01:12 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 400 | $59.54 | $23,816.00 |
DisclosureSEC source: 0001938861-25-000004 · wk-form4_1739927525.xml · nonDerivative · entry 3 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,478 F3 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:12 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 11,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001938861-25-000004 · wk-form4_1739927525.xml · nonDerivative · entry 2 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,878 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:12 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 16,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001938861-25-000004 · wk-form4_1739927525.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 72,562 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025. Read SEC document |
| January 13, 2025 Filed Jan 13, 2025 21:15 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 400 | $53.92 | $21,568.00 |
DisclosureSEC source: 0001938861-25-000002 · wk-form4_1736802904.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,588 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024. Read SEC document |
| December 13, 2024 Filed Dec 16, 2024 21:20 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 250 | $56.24 | $14,060.00 |
DisclosureSEC source: 0001938861-24-000032 · wk-form4_1734384022.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 55,988 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| November 13, 2024 Filed Nov 14, 2024 21:16 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 250 | $61.36 | $15,340.00 |
DisclosureSEC source: 0001938861-24-000030 · wk-form4_1731618972.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,238 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| October 14, 2024 Filed Oct 15, 2024 21:57 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 250 | $57.19 | $14,297.50 |
DisclosureSEC source: 0001938861-24-000028 · wk-form4_1729029460.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,488 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| September 13, 2024 Filed Sep 16, 2024 20:50 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 250 | $56.82 | $14,205.00 |
DisclosureSEC source: 0001938861-24-000026 · wk-form4_1726519846.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,738 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| August 13, 2024 Filed Aug 14, 2024 12:29 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 250 | $59.62 | $14,905.00 |
DisclosureSEC source: 0001938861-24-000023 · wk-form4_1723638583.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,988 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| July 18, 2024 Filed Jul 19, 2024 21:27 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,743 | $61.35 | $106,933.05 |
DisclosureSEC source: 0001938861-24-000020 · wk-form4_1721424440.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,238 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,820 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| July 12, 2024 Filed Jul 15, 2024 20:38 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 250 | $64.91 | $16,227.50 |
DisclosureSEC source: 0001938861-24-000018 · wk-form4_1721075886.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,981 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 21:23 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 250 | $63.80 | $15,950.00 |
DisclosureSEC source: 0001938861-24-000016 · wk-form4_1718400226.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,231 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| May 13, 2024 Filed May 13, 2024 21:25 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 250 | $67.69 | $16,922.50 |
DisclosureSEC source: 0001938861-24-000014 · wk-form4_1715635512.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,481 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| April 12, 2024 Filed Apr 15, 2024 22:28 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 250 | $67.79 | $16,947.50 |
DisclosureSEC source: 0001938861-24-000012 · wk-form4_1713220119.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,731 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| March 13, 2024 Filed Mar 13, 2024 20:48 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 250 | $66.54 | $16,635.00 |
DisclosureSEC source: 0001938861-24-000010 · wk-form4_1710362889.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,981 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 21:57 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,173 | $67.67 | $79,376.91 |
DisclosureSEC source: 0001938861-24-000008 · wk-form4_1709330246.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,231 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,039 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:28 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 9,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001938861-24-000006 · wk-form4_1708118895.xml · nonDerivative · entry 2 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,404 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:28 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 14,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001938861-24-000006 · wk-form4_1708118895.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,562 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024. Read SEC document |
| February 13, 2024 Filed Feb 14, 2024 01:05 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 250 | $56.04 | $14,010.00 |
DisclosureSEC source: 0001938861-24-000004 · wk-form4_1707872714.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,799 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 02:09 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 250 | $56.43 | $14,107.50 |
DisclosureSEC source: 0001938861-24-000002 · wk-form4_1705457345.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,049 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
| December 11, 2023 Filed Dec 11, 2023 22:49 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 250 | $49.21 | $12,302.50 |
DisclosureSEC source: 0001938861-23-000008 · wk-form4_1702334937.xml · nonDerivative · entry 1 Cook Meredith · CIK 0001938861 · SR. VP, GENERAL COUNSEL & SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,299 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.